Hillsdale Investment Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,022
Closed -$468K 637
2023
Q4
$468K Sell
1,022
-150
-13% -$73.9K 0.04% 322
2023
Q3
$570K Buy
1,172
+480
+69% +$226K 0.05% 232
2023
Q2
$309K Sell
692
-130
-16% -$65.4K 0.03% 315
2023
Q1
$399K Buy
822
+22
+3% +$10.9K 0.03% 379
2022
Q4
$410K Buy
+800
New +$420K 0.03% 381
2020
Q4
Sell
-1,255
Closed -$519K 624
2020
Q3
$519K Sell
1,255
-100
-7% -$40.2K 0.05% 310
2020
Q2
$526K Sell
1,355
-100
-7% -$37.4K 0.05% 308
2020
Q1
$457K Buy
+1,455
New +$491K 0.06% 306
2018
Q4
Sell
-1,540
Closed -$521K 611
2018
Q3
$521K Hold
1,540
0.07% 169
2018
Q2
$459K Sell
1,540
-110
-7% -$32.2K 0.06% 202
2018
Q1
$443K Sell
1,650
-140
-8% -$37.9K 0.06% 195
2017
Q4
$444K Sell
1,790
-100
-5% -$24.7K 0.07% 216
2017
Q3
$461K Buy
1,890
+300
+19% +$73.5K 0.08% 192
2017
Q2
$383K Sell
1,590
-10
-0.6% -$2.26K 0.07% 203
2017
Q1
$330K Buy
1,600
+1,300
+433% +$269K 0.07% 217
2016
Q4
$61K Buy
+300
New +$57.2K 0.01% 304

Other funds holding HUM

Hillsdale Investment Management's HUM Position: Q1 2024 in Review

Hillsdale Investment Management sold out of Humana (HUM) in Q1 2024, closing a stake of 1,022 shares — an estimated $468K sold.

Hillsdale Investment Management first reported a position in HUM in Q4 2016 and held it in 16 quarters. The position peaked at $570K in Q3 2023. 1,030 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Hillsdale Investment Management reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 1,022 Humana shares in Q1 2024, an estimated $468K.
  • Hillsdale Investment Management first reported a position in Humana in Q4 2016 and held it in 16 quarters.
  • Hillsdale Investment Management's Humana position peaked at $570K in Q3 2023.
  • 1,030 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Hillsdale Investment Management's 13F filing for Q1 2024, filed 10 May 2024.